Related Experiment Videos
Liver transplantation for hepatocellular carcinoma
1Department of Surgery, Pittsburgh Transplant Institute, Falk Clinic, Pennsylvania 15213, USA.
World Journal of Surgery
|January 1, 1995
Summary
Liver transplantation offers a 36% 5-year survival for hepatoma patients unsuitable for resection. Early stage identification through screening is crucial for successful liver transplantation outcomes.
Area of Science:
- Hepatobiliary Surgery
- Transplant Oncology
- Gastroenterology
Background:
- Hepatocellular carcinoma (HCC) poses a significant challenge, particularly in patients ineligible for liver resection.
- Liver transplantation is a potential curative option for advanced HCC, but outcomes vary significantly with disease stage.
Purpose of the Study:
- To evaluate the long-term survival outcomes of patients undergoing total hepatectomy plus liver transplantation for unresectable HCC.
- To identify prognostic factors influencing survival after liver transplantation for HCC.
Main Methods:
- A retrospective analysis of 105 patients who underwent total hepatectomy and liver transplantation.
- Correlation of postoperative survival with tumor pathologic stage, nodal status, tumor burden, and venous invasion.
Main Results:
- Overall 5-year survival was 36%. Survival rates decreased with advancing pathologic stage (Stage I: 75% to Stage IVA: 11%).
- Nodal disease, bilobar tumor, and macroscopic venous invasion were identified as significant poor-prognostic factors.
- An aggressive surgical approach (en bloc resection plus transplantation) for advanced stage IVA disease showed limited success, with high rates of recurrence.
Conclusions:
- Successful liver transplantation for hepatoma is highly dependent on early disease detection via screening programs.
- Effective neoadjuvant therapies are needed to manage microscopic distant metastases in patients with advanced HCC prior to transplantation.